Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-076583
Filing Date
2025-05-22
Accepted
2025-05-22 19:42:42
Documents
2
Period of Report
2025-05-20

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 8685
2 EX-24 ck0002040807-ex24.htm EX-24 20598
  Complete submission text file 0000950170-25-076583.txt   30758
Mailing Address C/O NEUMORA THERAPEUTICS, INC. 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address
Pinto Joshua (Reporting) CIK: 0001992595 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42489 | Film No.: 25978829

Mailing Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007
Business Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007 (212) 784-6595
Metsera, Inc. (Issuer) CIK: 0002040807 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)